Meet the Oncology & Hematology Medical Consulting Team

Covance has a dedicated team of over 50 oncology physicians with an average of 23 years of industry and clinical experience, in countries across Europe, North America, Latin America and Asia. Covance physicians’ experience extend from translational/early phase development through product launch, late-phase/post marketing studies. Our medical team has been carefully selected based upon clinical, academic, and industry experience that cover the majority of oncology indications including pediatric oncology.

Within this Oncology medical team is a specialized team of Oncology medical consultants. This team provides expertise in life-cycle management of specific tumor indications including clinical development planning and strategy, establishment of target product profiles, program feasibility, risk assessment, and execution, registries, as well as program- and study-level medical oversight. They will share their collective expertise with you throughout your entire clinical journey to help you bring crucial treatments safely and efficiently to oncology patients.


Meet the Team

Ariel E. Aguiló, MD
Senior Medical Director

Ariel Aguiló, MD, is Senior Medical Director for Covance Clinical Development Services, based in Buenos Aires, Argentina. He provides subject matter expertise and support for the development and conduct of clinical trials on clients’ drug development projects. Dr. Aguiló performs medical monitoring and data review, contributes to the medical strategy and execution of clinical programs, and brings scientific strategic leadership to the Oncology area at Covance. He brings 10 years of experience as a physician, medical advisor and medical director in drug research and development to Covance. Before joining Covance, he served as Medical Director for Syneos Health in Buenos Aires, and prior to that, served as Medical Advisor for IQVIA in Buenos Aires. He began his career as Attending Physician, GI Oncology Department, Hospital de Gastroenterologia. Dr. Aguiló joined Covance in 2012.

Ariel E. Aguiló, MD Senior Medical Director

Stefanella Bortini, PhD, MD
Senior Medical Director

Stefanella Bortini, MD, PhD, is Senior Medical Director, Oncology, for Covance Clinical Development Services, based in Milano, Italy. She contributes to the development of Covance policies involving medical, safety and therapeutics, and serves as global lead project physician on assigned projects. Dr. Bortini brings more than 30 years of experience in clinical research to Covance. Before joining the company, she was Senior Director, Medical Affairs, Oncology, for Chiltern International in Milan. She also has held positions with i3 Research, PRA International, Pharmacia & Upjohn, and Eli Lilly. Dr. Bortini is medically licensed by the Italian Board of Medical and Surgical Examiners and holds ECFMG Medical Certification for the U.S. She received her medical degree from the University of Firenze in Italy, and her PhD in Biomedical Engineering from Northwestern University. She joined Covance in July 2019.

Stefanella Bortini, PhD, MD Senior Medical Director

Begoña de las Heras, MD
Senior Medical Director

Dr. Begoña de las Heras Garcia serves as project physician on clients’ drug development projects, oversees three oncology physicians as part of the Covance Medical Consulting Team in Oncology and is building a global network of sites with expertise in early phase oncology. She brings more than 20 years of national and international clinical oncology research experience and joined Covance in 2016.

Before joining Covance, she served as Executive Medical Officer, Early Phase, for Chiltern in the UK. She also has held clinical research positions with Eisai in the UK and a several organizations in Spain including Pivotal CRO, PharmaMar, AstraZeneca and Bristol-Myers Squibb. She has worked as an oncologist consultant in Ntra Sra. Del Prado Hospital, La Paz Hospital, and General Yagüe Hospital. She has provided significant contribution to several INDs, orphan drug applications, and one NDA, and also co-authored eight book chapters, authored/co-authored more than 20 papers in oncology, and delivered more than 40 presentations in Spanish and at international conferences. She is named as an inventor of two patent applications, according to her contribution to clinical trials and is a member of the Spanish Society of Medical Oncology, European Society of Clinical Oncology, American Society of Clinical Oncology and Madrid Medical School. 

Begoña de las Heras, MD Senior Medical Director

He Huang, MD
Senior Medical Director

He Huang is Senior Director, Asia Pacific (APAC) for Covance Clinical Development Services, based in Shanghai, China.  He brings more than 10 years of experience as a physician and researcher in oncology, respiratory therapy and drug development to Covance. Before joining Covance, He served as Disease Area Head, Oncology/GI, for Bristol-Myers Squibb in Shanghai. He also served as Senior Manager, Respiratory, for AstraZeneca, and Medical Manager, Oncology/GI, for Roche, in Shanghai. He received the Global Champion and China CEO award at AstraZeneca. He began career as Medical Oncologist at Affiliated Hospital of Tongji Medical College of Huazhong University of Science and Technology in Wuhan, China. He joined Covance in September 2019.

He Huang, MD Senior Medical Director

Geoffrey Kannan, PhD, MD
Medical Director

Geoffrey Kannan, PhD, MD, is Medical Director, Oncology, for Covance Clinical Development Services, based in Princeton, New Jersey. Dr. Kannan serves as global lead project physician on clients’ drug development projects, providing medical expertise and support in the development and conduct of clinical trials. Dr. Kannan brings more than 10 years of experience as a physician and medical director to Covance, specializing in oncology and pediatrics. Before joining Covance, he served as Pediatric Hematologist/Oncologist and Pediatric Neuro-oncologist at Pediatric Specialists of Virginia. Prior to that, he served as Instructor of Pediatrics and Pediatric Neuro-oncologist for the Department of Pediatric Neuro-oncology, Dana-Farber Cancer Institute/Boston Children’s Hospital/Harvard Medical School. The author or co-author of more than 30 peer-reviewed journal articles, presentations and abstracts, Dr. Kannan joined Covance in November 2018.

Geoffrey Kannan, PhD MD Medical Director

Carlo Lanza, MD, PhD, MSc
Executive Medical Officer

Carlo Lanza, MD, PhD, is Executive Medical Officer for Covance Clinical Development Services, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase 1-4 clinical trials for Covance clients. He leads early phase and translational research early development programs with targeted therapies, small molecules, biologics and gene therapy. Dr. Lanza also oversees development of late-stage development strategies, delivery and approval of registrational programs. He brings more than 20 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology. Before joining Covance, he served as Medical Director for Medicines for Malaria Venture in Geneva, Switzerland. Dr. Lanza has also held leadership positions with Novartis Oncology, Pfizer Global R&D, and AstraZeneca UK. Carlo joined Covance in 2012.

Carlo Lanza, MD, PhD, MSc Executive Medical Officer

Martine Poelman, MD
Executive Medical Director

Martine Poelman is Executive Medical Director, Oncology, for Covance Clinical Development Services, based in Brussels, Belgium. She provides medical and scientific support to help advance drug development in hematological malignancies for Covance clients. Martine brings more than 30 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology, to Covance. Before assuming her current position, Martine served more than 15 years as Global Head of Oncology Research for Covance, providing medical monitoring for more than 200 clinical trials. Before joining Covance, she served as Clinical Research Physician, Hemato-Oncology-Infectiology, for Eli Lilly in Brussels. Before going into research, she served as Bone Marrow Transplantation and Hemato-Oncology Physician for the Department of Pediatric Oncology, Wilhelmina Children’s Hospital, in The Netherlands. Martine joined Covance in November 1996.

Martine-Poelman-WEB

Kamal Veer Saini, MD, MRCP (UK)
Senior Medical Director

Dr. Kamal Veer Saini is a board-certified medical oncologist based in Brussels, Belgium. As Senior Medical Director at Covance, he contributes to medical strategy in the oncology area and client consulting and engagement on asset development and all related aspects of medical and scientific execution.

He has more than 15 years of experience in academia and industry, having held numerous posts of increasing seniority across all phases of clinical drug development in various cancer types (solid tumors as well as hematological malignancies) with both regional and global responsibility.

Kamal Veer Saini

Ivana Teodorovic, MD
Senior Medical Director

Ivana Teodorovic, MD, is Senior Medical Director for Covance Clinical Development Services, based in Brussels, Belgium. Dr. Teodorovic serves as project physician and provides scientific support on global and regional oncology studies for Covance clients. She develops, reviews and revises protocols, and coordinates and performs medical monitoring and review of patient data. Dr. Teodorovic brings more than 30 years of experience as a physician and medical director in drug research and development. Before joining Covance, she served more than 10 years as Coordinating Physician for the European Organization for Research and Treatment of Cancer Data Center Company (EORTC) in Brussels, where she authored the SOP-EORTC Tissue Research Policy. Dr. Teodorovic began her career as a certified anatomopathologist at the Institute for Oncology and Radiology in Belgrade, Serbia. She joined Covance in May 2005.

Ivana Teodorovic, MD Senior Medical Director